Radiolabeled Antibody Therapy Of B Cell Lymphoma With Autologous Bone Marrow Support

Find all needed information about Radiolabeled Antibody Therapy Of B Cell Lymphoma With Autologous Bone Marrow Support. Below you can see links where you can find everything you want to know about Radiolabeled Antibody Therapy Of B Cell Lymphoma With Autologous Bone Marrow Support.


Radiolabeled-Antibody Therapy of B-Cell Lymphoma with ...

    https://www.nejm.org/doi/full/10.1056/NEJM199310213291702
    Original Article from The New England Journal of Medicine — Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow SupportCited by: 993

Myeloablative Radiolabeled Antibody Therapy with ...

    https://link.springer.com/chapter/10.1007/978-1-4615-2013-9_13
    Press OW, Eary J, Appelbaum F, et al.: Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 329:1219, 1993. PubMed CrossRef Google ScholarCited by: 7

Biodistribution and Dosimetry of 177Lu-tetulomab, a New ...

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624777/
    Press OW, Eary JF, Appelbaum FR, Martin PJ, Badger CC, Nelp WB, Glenn S, Butchko G, Fisher D, Porter B. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N. Engl.Cited by: 23

Monoclonal antibodies and autologous stem cell ...

    https://www.nature.com/articles/1702857
    Apr 23, 2001 · Autologous marrow grafts from 114 B cell malignancy patients were purged in vitro with a cocktail of anti-B cell monoclonal antibodies (anti-B1, anti-B5, anti-J5). The efficacy of the marrow ...Cited by: 14

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral ...

    https://clinicaltrials.gov/ct/show/NCT00004107
    DISEASE CHARACTERISTICS: Histologically or cytologically proven B cell lymphoma of one of the following types: Any histologic grade of non-Hodgkin's lymphoma Chronic lymphocytic leukemia CD22 positive acute lymphocytic leukemia Waldenstrom's macroglobulinemia Must have failed at least 1 standard therapy Autologous peripheral blood stem cells (PBSC) or bone marrow available Bone marrow ...

High‐dose myeloablative radioimmunotherapy of mantle cell ...

    https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.10307
    High‐dose myeloablative radioimmunotherapy of mantle cell non‐hodgkin lymphoma with the iodine‐131–labeled chimeric anti‐CD20 antibody C2B8 and autologous stem cell support. [THIS ARTICLE HAS BEEN RETRACTED] Results of a pilot studyCited by: 100

Radioimmunotherapy: A New Treatment Modality for B-Cell ...

    https://www.cancernetwork.com/leukemia-lymphoma/radioimmunotherapy-new-treatment-modality-b-cell-non-hodgkins-lymphoma/page/0/1
    Aug 25, 2019 · Goldenberg DM: The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: The coming of age of radioimmunotherapy. Crit Rev Oncol Hematol 39:195-201, 2001. 36. Sharkey RM, Behr TM, Mattes MJ, et al: Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22. Cancer ImmunolCited by: 13



Need to find Radiolabeled Antibody Therapy Of B Cell Lymphoma With Autologous Bone Marrow Support information?

To find needed information please read the text beloow. If you need to know more you can click on the links to visit sites with more detailed data.

Related Support Info